Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Angelo Antonini, A. Jon Stoessl, Leah S. Kleinman, Anne M. Skalicky, Thomas S. Marshall, Kavita R. Sail, Koray Onuk & Per Lars Anders Odin. (2018) Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease: a multi-country Delphi-panel approach. Current Medical Research and Opinion 34:12, pages 2063-2073.
Read now
Read now
Stephen W Pedersen, Martin Suedmeyer, Louis W C Liu, Dirk Domagk, Alison Forbes, Lars Bergmann, Koray Onuk, Ashley Yegin & Teus van Laar. (2017) The role and structure of the multidisciplinary team in the management of advanced Parkinson’s disease with a focus on the use of levodopa–carbidopa intestinal gel. Journal of Multidisciplinary Healthcare 10, pages 13-27.
Read now
Read now
Articles from other publishers (39)
Irene A. Malaty, Pablo Martinez-Martin, K. Ray Chaudhuri, Per Odin, Matej Skorvanek, Joohi Jimenez-Shahed, Michael J. Soileau, Susanna Lindvall, Josefa Domingos, Sarah Jones, Ali Alobaidi, Yash J. Jalundhwala, Prasanna L. Kandukuri, Koray Onuk, Lars Bergmann, Samira Femia, Michelle Y. Lee, Jack Wright & Angelo Antonini. (2022) Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries. BMC Neurology 22:1.
Crossref
Crossref
Alessandro Stefani, Alessandro Tessitore, Nicola Tambasco, Giovanni Cossu, Maria Gabriella Ceravolo, Giovanni Defazio, Francesca Morgante, Silvia Ramat, Gabriella Melzi, Giuliana Gualberti, Rocco Merolla, Koray Onuk & Leonardo Lopiano. (2022) Criteria for identification of advanced Parkinson’s disease: the results of the Italian subgroup of OBSERVE-PD observational study. BMC Neurology 22:1.
Crossref
Crossref
Tove Lise Nielsen, Naja Benigna Kruse, Anita Haahr, Ellen Gabrielsen Hjelle, Line Kildal Bragstad, Ana Palmar‐Santos, Maria Victoria Navarta‐Sánchez, Azucena Pedraz‐Marcos, Sandra Bartolomeu Pires, Helen C. Roberts & Mari Carmen Portillo. (2022) Exploring health and social services in Denmark, Norway, Spain and the United Kingdom for the development of Parkinson's care pathways. A document analysis. Health & Social Care in the Community 30:6.
Crossref
Crossref
Ria Shah, Joy Read, Nathan Davies, Danielle Nimmons, Jennifer Pigott, Anette Schrag, Kate Walters & Megan Armstrong. (2022) People with Parkinson’s perspectives and experiences of self-management: Qualitative findings from a UK study. PLOS ONE 17:9, pages e0273428.
Crossref
Crossref
József Attila Szász, Viorelia Adelina Constantin, Károly Orbán-Kis, Ligia Ariana Bancu, Simona Maria Bataga, Marius Ciorba, Előd Nagy, Mircea Radu Neagoe, István Mihály, Róbert Máté Szász, Krisztina Kelemen, Mihaela Simu & Szabolcs Szatmári. (2022) Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: Observations and Dilemmas after 10 Years of Real-Life Experience. Pharmaceutics 14:6, pages 1115.
Crossref
Crossref
Zhao H.K. Goh, Julia L.Y. Cheong, Connie Marras, Caroline M. Tanner, Meike Kasten, Amos D. Korczyn, Lana Chahine, Raymond Lo & Alastair J. Noyce. (2022) Surveying Global Availability of Parkinson’s Disease Treatment. Journal of Parkinson's Disease 12:3, pages 1023-1034.
Crossref
Crossref
Angelo Antonini, Rajesh Pahwa, Per Odin, Tove Henriksen, Michael J. Soileau, Ramon Rodriguez-Cruz, Stuart H. Isaacson, Aristide Merola, Susanna Lindvall, Josefa Domingos, Ali Alobaidi, Yash J. Jalundhwala, Prasanna L. Kandukuri, Juan Carlos Parra, Pavnit K. Kukreja, Koray Onuk, Lars Bergmann, James Pike & K. Ray Chaudhuri. (2022) Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries. Neurology and Therapy 11:1, pages 303-318.
Crossref
Crossref
Angelo Antonini, Per Odin, Peter Schmidt, Fernando Cubillos, David G. Standaert, Tove Henriksen, Joohi Jimenez-Shahed, Ali Alobaidi, Yash J. Jalundhwala, Yanjun Bao, Jorge Zamudio, Juan Carlos Parra, Pavnit Kukreja, Koray Onuk, Anne M. Skalicky, Leah Kleinman, Eddie Jones, Sharon Metz & Hubert H. Fernandez. (2021) Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications. Parkinsonism & Related Disorders 92, pages 59-66.
Crossref
Crossref
Jenny M. Norlin, Michael Willis, Ulf Persson, Emelie Andersson, Sven Pålhagen & Per Odin. (2021) Swedish guidelines for device‐aided therapies in Parkinson's disease —Economic evaluation and implementation. Acta Neurologica Scandinavica 144:2, pages 170-178.
Crossref
Crossref
Angelo Antonini, Per Odin, Rajesh Pahwa, Jason Aldred, Ali Alobaidi, Yash J. Jalundhwala, Pavnit Kukreja, Lars Bergmann, Sushmitha Inguva, Yanjun Bao & K. Ray Chaudhuri. (2021) The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on ‘Off’-time in Patients with Advanced Parkinson’s Disease: A Systematic Review. Advances in Therapy 38:6, pages 2854-2890.
Crossref
Crossref
Francesca Morgante, Valentina Oppo, Margherita Fabbri, Enrica Olivola, Chiara Sorbera, Rosa De Micco, Giovanna Chiara Ielo, Fabiana Colucci, Salvatore Bonvegna, Alessio Novelli, Nicola Modugno, Mariachiara Sensi, Maurizio Zibetti, Leonardo Lopiano, Alessandro Tessitore, Manuela Pilleri, Roberto Cilia, Antonio E. Elia, Roberto Eleopra, Lucia Ricciardi & Giovanni Cossu. (2020) Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age. Journal of Neurology 268:5, pages 1728-1737.
Crossref
Crossref
Shweta Prasad, Amitabh Bhattacharya, Lulup Kumar Sahoo, Dhruv Batra, Nitish Kamble, Ravi Yadav, Dwarakanath Srinivas & Pramod Kumar Pal. (2021) Knowledge, Attitude, and Perceptions about Deep Brain Stimulation for Parkinson’s Disease: Observations from a Single Indian Center. Journal of Movement Disorders 14:1, pages 60-64.
Crossref
Crossref
Onanong Phokaewvarangkul, Somchit Vorachit, Appasone Phoumindr, Saysavath Keosodsay, Ronald B. Postuma, Wassilios G. Meissner & Roongroj Bhidayasiri. (2020) Addressing knowledge gaps in Parkinson’s disease: a report on the Movement Disorder Society’s Centre-to-Centre initiative to improve Parkinson’s disease services in Lao People’s Democratic Republic. BMC Medical Education 20:1.
Crossref
Crossref
Xing Yan Choo, Shen-Yang Lim, Karuthan Chinna, Yan Jing Tan, Voon Wei Yong, Jia Lun Lim, Kar Foo Lau, Jing Yi Chung, Jun Min Em, Hui Ting Tan, Jia Hwa Lim, Seng Beng Tan, Chong Tin Tan & Ai Huey Tan. (2020) Understanding patients’ and caregivers’ perspectives and educational needs in Parkinson’s disease: a multi-ethnic Asian study. Neurological Sciences 41:10, pages 2831-2842.
Crossref
Crossref
Hamdi Aloulou, Mounir Mokhtari & Bessam Abdulrazak. (2020) Pilot Site Deployment of an IoT Solution for Older Adults’ Early Behavior Change Detection. Sensors 20:7, pages 1888.
Crossref
Crossref
D. Santos-García, T. de Deus Fonticoba, E. Suárez Castro, A. Aneiros Díaz & D. McAfee. (2020) 5-2-1 Criteria: A Simple Screening Tool for Identifying Advanced PD Patients Who Need an Optimization of Parkinson’s Treatment. Parkinson's Disease 2020, pages 1-6.
Crossref
Crossref
Hayrettin O. Gülcan & Ilkay E. Orhan. (2020) The Main Targets Involved in Neuroprotection for the Treatment of Alzheimer’s Disease and Parkinson Disease. Current Pharmaceutical Design 26:4, pages 509-516.
Crossref
Crossref
Elisa Montanaro, Carlo Alberto Artusi, Maurizio Zibetti & Leonardo Lopiano. (2019) Complex therapies for advanced Parkinson’s disease: what is the role of doctor-patient communication?. Neurological Sciences 40:11, pages 2357-2364.
Crossref
Crossref
Frouke A. P. Nijhuis, Lieneke van den Heuvel, Bastiaan R. Bloem, Bart Post & Marjan J. Meinders. (2019) The Patient's Perspective on Shared Decision-Making in Advanced Parkinson's Disease: A Cross-Sectional Survey Study. Frontiers in Neurology 10.
Crossref
Crossref
Melissa J. Armstrong, Tara Rastgardani, Anna R. Gagliardi & Connie Marras. (2019) Barriers and facilitators of communication about off periods in Parkinson’s disease: Qualitative analysis of patient, carepartner, and physician Interviews. PLOS ONE 14:4, pages e0215384.
Crossref
Crossref
Gabriela Postolache & Octavian Postolache. 2019. Mobile Solutions and Their Usefulness in Everyday Life. Mobile Solutions and Their Usefulness in Everyday Life
251
273
.
Hamdi Aloulou, Mounir Mokhtari & Bessam Abdulrazak. 2019. How AI Impacts Urban Living and Public Health. How AI Impacts Urban Living and Public Health
27
35
.
Mounir Mokhtari, Antoine de Marassé, Martin Kodys & Hamdi Aloulou. 2019. HCI International 2019 – Late Breaking Posters. HCI International 2019 – Late Breaking Posters
251
258
.
Alessandro Tessitore, Pietro Marano, Nicola Modugno, Francesco E. Pontieri, Nicola Tambasco, Margherita Canesi, Anna Latorre, Leonardo Lopiano, Mariachiara Sensi, Rocco Quatrale, Paolo Solla, Giovanni Defazio, Gabriella Melzi, Anna Maria Costanzo, Giuliana Gualberti, Umberto di Luzio Paparatti & Angelo Antonini. (2018) Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study. Journal of Neurology 265:5, pages 1124-1137.
Crossref
Crossref
Nataliya Titova, Pablo Martinez-Martin, Elena Katunina & K. Ray Chaudhuri. (2017) Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed. Journal of Neural Transmission 124:12, pages 1529-1537.
Crossref
Crossref
Åsa Snöljung, Jenny Kärrholm, Elin Hinas & Kristina Alexanderson. (2017) Neurologists dealing with sickness certification: Experiences of problems and need of competence. Brain and Behavior 7:11, pages e00845.
Crossref
Crossref
Max Lange, Josef Mauerer, Jürgen Schlaier, Annette Janzen, Florian Zeman, Ulrich Bogdahn, Alexander Brawanski & Andreas Hochreiter. (2017) Underutilization of deep brain stimulation for Parkinson’s disease? A survey on possible clinical reasons. Acta Neurochirurgica 159:5, pages 771-778.
Crossref
Crossref
Beriwan Ezat, Lasse Pihlstrøm, Jan Aasly, Ole-Bjørn Tysnes, Arild Egge & Espen Dietrichs. (2017) Bruk av avansert behandling ved Parkinsons sykdom i Norge. Tidsskrift for Den norske legeforening 137:9, pages 619-623.
Crossref
Crossref
Frouke A.P. Nijhuis, Jolien van Heek, Bastiaan R. Bloem, Bart Post & Marjan J. Faber. (2016) Choosing an Advanced Therapy in Parkinson’s Disease; is it an Evidence-Based Decision in Current Practice?. Journal of Parkinson's Disease 6:3, pages 533-543.
Crossref
Crossref
Elena Moro, Michael Schüpbach, Tobias Wächter, Niels Allert, Roberto Eleopra, Christopher R. Honey, Mauricio Rueda, Mya C. Schiess, Yasushi Shimo, Peter Valkovic, Alan Whone & Herman Stoevelaar. (2015) Referring Parkinson’s disease patients for deep brain stimulation: a RAND/UCLA appropriateness study. Journal of Neurology 263:1, pages 112-119.
Crossref
Crossref
Ai Huey Tan, Chong Tin Tan, Connie Marras, Kwong Weng Loh, Niki Wai Wye Ho, Quan Hziung Lim, Pei Wen Tan, Chee Chean Lim, Yee Weai Cheong, Sik Thien Kong, Jie Ping Schee, Kean Hoong Tan, Suet Ker Soo, Cheryl Vanderschaaf, Sara Lai Heong Lew, Ummi Affah Mahamad, Khean Jin Goh, Hoi Sen Yong & Shen-Yang Lim. (2015) Knowledge of Parkinson’s Disease in a Multiethnic Urban Asian Setting. Journal of Parkinson's Disease 5:4, pages 865-879.
Crossref
Crossref
P. Odin, K. Ray Chaudhuri, J.T. Slevin, J. Volkmann, E. Dietrichs, P. Martinez-Martin, J.K. Krauss, T. Henriksen, R. Katzenschlager, A. Antonini, O. Rascol & W. Poewe. (2015) Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program. Parkinsonism & Related Disorders 21:10, pages 1133-1144.
Crossref
Crossref
Jane Mills & Anne Martin. (2015) Parkinson's is complex: considering earlier use of advanced, non-oral therapies. British Journal of Neuroscience Nursing 11:2, pages 92-97.
Crossref
Crossref
Thomas Buckley, Helen Stasa, Andrew Cashin, Meg Stuart & Sandra V. Dunn. (2015) Sources of information used to support quality use of medicines: Findings from a national survey of nurse practitioners in Australia. Journal of the American Association of Nurse Practitioners 27:2, pages 87-94.
Crossref
Crossref
Rashmi Lakshminarayana, Duolao Wang, David Burn, K Ray Chaudhuri, Gemma Cummins, Clare Galtrey, Bruce Hellman, Suvankar Pal, Jon Stamford, Malcolm Steiger & Adrian Williams. (2014) Smartphone- and internet-assisted self-management and adherence tools to manage Parkinson’s disease (SMART-PD): study protocol for a randomised controlled trial (v7; 15 August 2014). Trials 15:1.
Crossref
Crossref
Regina Katzenschlager. 2014. Levodopa-Induced Dyskinesia in Parkinson's Disease. Levodopa-Induced Dyskinesia in Parkinson's Disease
69
88
.
Martijn van der Eijk, Frouke A.P. Nijhuis, Marjan J. Faber & Bastiaan R. Bloem. (2013) Moving from physician-centered care towards patient-centered care for Parkinson's disease patients. Parkinsonism & Related Disorders 19:11, pages 923-927.
Crossref
Crossref
Paul F Worth. (2013) When the going gets tough: how to select patients with Parkinson's disease for advanced therapies. Practical Neurology 13:3, pages 140-152.
Crossref
Crossref
Johan LökkSeyed-Mohammad Fereshtehnejad. (2013) Managing palliative care in Parkinson’s disease from diagnosis to end-stage disease: what the clinician should know. Neurodegenerative Disease Management 3:2, pages 169-183.
Crossref
Crossref